Kadmon Holdings - Stock Price History | KDMN

Historical daily share price chart and data for Kadmon Holdings since 2021 adjusted for splits. The latest closing stock price for Kadmon Holdings as of September 24, 2021 is 8.83.
  • The all-time high Kadmon Holdings stock closing price was 10.23 on August 16, 2016.
  • The Kadmon Holdings 52-week high stock price is 9.20, which is 4.2% above the current share price.
  • The Kadmon Holdings 52-week low stock price is 3.15, which is 64.3% below the current share price.
  • The average Kadmon Holdings stock price for the last 52 weeks is 4.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Kadmon Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.2322 4.4800 5.2600 2.4400 4.1500 -8.39%
2019 2.7266 2.2600 4.9800 1.6500 4.5300 117.79%
2018 3.5571 3.6400 5.8300 1.9300 2.0800 -42.54%
2017 3.3219 5.4000 5.4000 2.0900 3.6200 -32.34%
2016 7.1144 9.7000 10.2300 4.2300 5.3500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.532B $0.008B
Kadmon Holdings Inc. is a biopharmaceutical company. It discovers, develops and delivers transformative therapies for unmet medical needs. The company's product pipeline includes KD025, KD045 and KD033 which are in clinical satge. Kadmon Holdings Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71